Equity Capital Markets

Company · CIK 1805890

Fusion Pharmaceuticals Inc.

CIK1805890 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inZ4
Business addressOntario, Canada
Listedno ticker on SEC record today
First annual or quarterly report2020-08-11

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-257653
ShelfEffective
 2021-07-022024-06-074
333-270604
ShelfEffective
 2023-03-162024-06-073
333-272713
ShelfEffective
 2023-06-162024-06-073
333-238968
IPOFinal prospectus
 2020-06-052020-06-265

Filings

16
FiledFilingRegistrationAccession
2024-06-07EFFECTDeclared effective 333-2727139999999995-24-001778
2024-06-07EFFECTDeclared effective 333-2706049999999995-24-001777
2024-06-07EFFECTDeclared effective 333-2576539999999995-24-001776
2024-01-19424B5Shelf takedown 333-2576530001193125-24-011250
2023-06-27EFFECTDeclared effective 333-2727139999999995-23-001862
2023-06-16S-3Shelf registered 333-2727130001193125-23-168950
2023-03-23EFFECTDeclared effective 333-2706049999999995-23-000645
2023-03-16S-3Shelf registered 333-2706040001193125-23-072555
2021-07-13EFFECTDeclared effective 333-2576539999999995-21-002745
2021-07-02S-3Shelf registered 333-2576530001193125-21-207654
2020-06-26424B4Final prospectus 333-2389680001193125-20-181060
2020-06-25EFFECTDeclared effective 333-2389689999999995-20-001543
2020-06-24S-1/AAmendment 333-2389680001193125-20-177615
2020-06-22S-1/AAmendment 333-2389680001193125-20-174636
2020-06-05S-1Registration filed 333-2389680001193125-20-162195
2020-04-03DRSDraft made public 377-031080000950123-20-003115

All filings of this company · CSV